We investigated Lp (a) levels and apo (a) polymorphism in relation to the severity of
coronary artery disease, expressed both by the number of coronary arteries stenosed and …

Background: Studies on the impact of elevated levels of lipoprotein (a)(Lp [a]) or
apolipoprotein (a)(apo [a]) on the development of coronary artery disease have given …

Apolipoprotein (a)[apo (a)] is the specific apolipoprotein of lipoprotein (a)[Lp (a)], a
recognized cardiovascular risk factor. Apo (a) is characterized by a high genetic …

Background Apolipoprotein (a) isoforms of low-molecular weight are associated with
coronary heart disease. However, because of the high number of apolipoprotein (a) …

In the present paper, we have evaluated serum Lp (a) concentrations, the frequencies of Lp
(a) phenotypes and alleles and the association between the Lp (a) phenotypes and serum …

Lp (a) concentrations are largely determined by apo (a) isoform size, but several studies
have shown that apo (a) isoforms could not entirely explain the increase of Lp (a) levels …

To evaluate whether a high level of lipoprotein (a)(Lp (a)) is a risk for the development of
coronary heart disease (CHD), 94 Japanese patients and 64 age-matched Japanese …

Objectives. The purpose of this study was to investigate lipoprotein (a)[Lp (a)] levels and
apolipoprotein (a)[apo (a)] phenotypes in relation to age of onset of coronary heart disease …

Elevated concentrations of lipoprotein (a)(Lp [a]) in plasma are associated with premature
coronary heart disease (CHD). Lp (a) levels are largely determined by alleles at the …

Abstract Lipoprotein (a)[Lp (a)] is an atherogenic and prothrombotic molecule formed by the
covalent binding of the highly polymorphic apolipoprotein (a)[apo (a)] to apoprotein B-100 of …